Evalen 0.1% gel
Ferron Par Pharmaceuticals
Composition
| Adapalene | 1 mg |
Each Pack Contains
1 tube of 10 g
Dosage Form
 | gel |
Dosage formGel
Flavor
None
W.H.O. Classification
D10A
Available In
 | Indonesia |
Warning
Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.
Pregnancy
NOT RECOMMENDEDThis item is not safe for use during pregnancy.
Lactation
CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.
Indication
Acne vulgaris
Evalen gel 0.1% is used topically for the treatment of moderate to severe Acne Vulgaris
Evalen gel 0.1% is used topically for the treatment of moderate to severe Acne Vulgaris
Dosage
12 YEARS OLD AND ABOVE
Evalen gel 0.1% should be applied to the cleansed affected areas of the skin, once daily in the evening at bedtime. A thin film of Evalen gel 0.1% should be applied, avoiding contact with the eyes, lip, angle of the nose and mucous membranes. If product enters the eye, wash immediately with warm water. Ensure that the affected areas are dry before application.
During the early weeks of therapy, an apparent exacerbation of acne may occur. This effect is attributable to the action of the drug on previously unseen lesions and should not be considered a reason to discontinue therapy.
Since it is customary to alternate therapies in the treatment of acne, it is recommended that the physician assess improvement of patient disease after 3 months of treatment with Evalen gel 0.1%.
Patients who is necessary to reduce the frequency of application or to temporarily discontinue treatment, frequency of application may be restored or therapy resumed once it is judged that the patient can again tolerate the treatment.
Evalen gel 0.1% should be applied to the cleansed affected areas of the skin, once daily in the evening at bedtime. A thin film of Evalen gel 0.1% should be applied, avoiding contact with the eyes, lip, angle of the nose and mucous membranes. If product enters the eye, wash immediately with warm water. Ensure that the affected areas are dry before application.
During the early weeks of therapy, an apparent exacerbation of acne may occur. This effect is attributable to the action of the drug on previously unseen lesions and should not be considered a reason to discontinue therapy.
Since it is customary to alternate therapies in the treatment of acne, it is recommended that the physician assess improvement of patient disease after 3 months of treatment with Evalen gel 0.1%.
Patients who is necessary to reduce the frequency of application or to temporarily discontinue treatment, frequency of application may be restored or therapy resumed once it is judged that the patient can again tolerate the treatment.